Contribution: Canadian International Innovation Program
Aspect Biosystems Ltd.
$581,851.00
CIIP Korea Project 3D Printing Therapy
FY 2019-20 · 2019-10-28
Summary
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd. (Korea) and tissue engineering technologies from POSTECH (Korea). Together, this international team will create a comprehensive solution for 3D bioprinting implantable cardiac and pancreatic therapeutic tissues containing validated stem cell-derived cells as an important step towards the future treatment of patients with myocardial infarction or Type-1 Diabetes.
Department
Program
Canadian International Innovation Program
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
830167839
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-10-28 | 2019-20 | $600,000.00 |
| 1 | 2019-10-28 | 2019-20 | $581,851.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -18,149 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 18 149 dollars.
Agreement End Date
2021-10-31
Agreement Number
938664
Agreement Start Date
2019-10-28
Agreement Title
CIIP Korea Project 3D Printing Therapy
Agreement Title (French)
PCII en Corée - Projet de thérapie d'impression 3D
Agreement Type
Contribution
Agreement Value
$581,851.00
Amendment Date
2020-03-31
Amendment Number
1
Coverage
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access. | Le Programme canadien de l’innovation à l’international vise à appuyer les partenariats de recherche et développement industriels et les activités de jumelage entre les entreprises canadiennes et les partenaires étrangers, en vue d'accélérer la commercialisation et de faciliter l'accès aux marchés.
Description
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd. (Korea) and tissue engineering technologies from POSTECH (Korea). Together, this international team will create a comprehensive solution for 3D bioprinting implantable cardiac and pancreatic therapeutic tissues containing validated stem cell-derived cells as an important step towards the future treatment of patients with myocardial infarction or Type-1 Diabetes.
Description (French)
La Corée PCII projet 3D de la thérapie d'imprimerie intégrera la technologie unique bioprinting 3D d'aspect Biosystems Ltd. (Canada) avec la technologie des cellules souches pluripotentes de NEXEL Co., Ltd. (Corée) et les technologies du génie tissulaire de POSTECH (Corée). Ensemble, cette équipe internationale créera une solution globale pour bioprinting cardiaques implantables 3D et les tissus pancréatiques thérapeutiques contenant des cellules souches validées cell-derived comme une étape importante vers le traitement futur des patients souffrant d'un infarctus du myocarde ou le diabète de type 1.
Expected Results
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Expected Results (French)
Le Programme canadien de l’innovation à l’international favorise et appuie les projets de collaboration en matière de recherche-développement industrielle susceptibles d’être commercialisés entre le Canada et des pays partenaires. Il stimule les activités bilatérales de réseautage et de jumelage en science et technologie afin d’encourager la formation de nouveaux partenariats et d’accélérer la commercialisation de la recherche et du développement.
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Canadian International Innovation Program
Program Name (French)
Programme canadien d’innovation à l’international
Program Purpose
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Program Purpose (French)
Le Programme canadien de l’innovation à l’international favorise et appuie les projets de collaboration en matière de recherche-développement industrielle susceptibles d’être commercialisés entre le Canada et des pays partenaires. Il stimule les activités bilatérales de réseautage et de jumelage en science et technologie afin d’encourager la formation de nouveaux partenariats et d’accélérer la commercialisation de la recherche et du développement.
Recipient Business Number
830167839
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Aspect Biosystems Ltd.
Recipient Postal Code
V6P 6P2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2019-2020-Q3-938664
